Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cycloserine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cycloserine SCHEMBL8681114 | 0.97 | BLM (1.00) | — | |
| Cycloserine SCHEMBL8681117 | 0.97 | BLM (1.00) | — | |
| Cycloserine SCHEMBL34322 | 0.97 | — | — | |
| Cycloserine SCHEMBL34323 | 0.97 | — | — | |
| Levcycloserine SCHEMBL243772 | 0.97 | — | — | |
| Cycloserine SCHEMBL6571320 | 0.95 | — | — | |
| Cycloserine SCHEMBL3921591 | 0.87 | BLM (0.79) | — | |
| Cycloserine SCHEMBL14697213 | 0.85 | BLM (0.76) | — | |
| Cycloserine SCHEMBL5146943 | 0.79 | BLM (0.66) | — | |
| Sulfanilamide SCHEMBL7459810 | 0.74 | TSHR (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012011112-A1 | NON PSYCHOACTIVE CANNABINOIDS AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2012-01-26 | — | — | WO | claimed |